Cargando…
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients
MicroRNAs fine-tune the regulation of Th1/Th17 lymphocyte subsets in multiple sclerosis. We investigated the expression of miRNAs (previously associated with mycobacterial and viral infections) in MS patients and healthy donors (HD) following 6 months natalizumab therapy. In addition, Th1/Th17 cytok...
Autores principales: | Mameli, Giuseppe, Arru, Giannina, Caggiu, Elisa, Niegowska, Magdalena, Leoni, Stefania, Madeddu, Giordano, Babudieri, Sergio, Sechi, Gian Pietro, Sechi, Leonardo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911163/ https://www.ncbi.nlm.nih.gov/pubmed/27310932 http://dx.doi.org/10.1371/journal.pone.0157153 |
Ejemplares similares
-
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
por: Caggiu, Elisa, et al.
Publicado: (2018) -
Inflammation, Infectious Triggers, and Parkinson's Disease
por: Caggiu, Elisa, et al.
Publicado: (2019) -
miR-1, miR-10b, miR-155, and miR-191 are novel regulators of BDNF
por: Varendi, Kärt, et al.
Publicado: (2014) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
Effect of miR-146a and miR-155 on cardiac xenotransplantation
por: Zhao, Zhicheng, et al.
Publicado: (2016)